Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions

NCT00832481 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Repaglinide
DRUG: Metformin

Sponsor

Chinese PLA General Hospital